| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10718 | 2021 |
| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... Nature 500 (7463), 415-421, 2013 | 9770 | 2013 |
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2171 | 2016 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1671* | 2020 |
| HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ... Nature medicine 23 (4), 517-525, 2017 | 920 | 2017 |
| Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes JB de Kok, RW Roelofs, BA Giesendorf, JL Pennings, ET Waas, T Feuth, ... Laboratory investigation 85 (1), 154-159, 2005 | 706 | 2005 |
| Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy TWH Meijer, JHAM Kaanders, PN Span, J Bussink Clinical cancer research 18 (20), 5585-5594, 2012 | 499 | 2012 |
| ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands WJ Welboren, MA Van Driel, EM Janssen‐Megens, SJ Van Heeringen, ... The EMBO journal 28 (10), 1418-1428, 2009 | 472 | 2009 |
| Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ... Science 345 (6196), 1251343, 2014 | 437 | 2014 |
| Multicenter validation of a gene expression–based prognostic signature in lymph node–negative primary breast cancer JA Foekens, D Atkins, Y Zhang, FCGJ Sweep, N Harbeck, A Paradiso, ... Journal of Clinical Oncology 24 (11), 1665-1671, 2006 | 437 | 2006 |
| Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial GO Janssens, SE Rademakers, CH Terhaard, PA Doornaert, HP Bijl, ... Journal of clinical oncology 30 (15), 1777-1783, 2012 | 298 | 2012 |
| Somatic mutations reveal asymmetric cellular dynamics in the early human embryo YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ... Nature 543 (7647), 714-718, 2017 | 279 | 2017 |
| The topography of mutational processes in breast cancer genomes S Morganella, LB Alexandrov, D Glodzik, X Zou, H Davies, J Staaf, ... Nature communications 7 (1), 11383, 2016 | 272 | 2016 |
| Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response A Nagelkerke, J Bussink, H Mujcic, BG Wouters, S Lehmann, ... Breast Cancer Research 15, 1-13, 2013 | 250 | 2013 |
| A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer A Eustace, N Mani, PN Span, JJ Irlam, J Taylor, GNJ Betts, H Denley, ... Clinical cancer research 19 (17), 4879-4888, 2013 | 249 | 2013 |
| TRPM7 is required for breast tumor cell metastasis J Middelbeek, AJ Kuipers, L Henneman, D Visser, I Eidhof, ... Cancer research 72 (16), 4250-4261, 2012 | 247 | 2012 |
| Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients MM Nijkamp, PN Span, IJ Hoogsteen, AJ van der Kogel, JHAM Kaanders, ... Radiotherapy and Oncology 99 (3), 344-348, 2011 | 247 | 2011 |
| Corrigendum: Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, S Aparicio, S Behjati, ... Nature 502 (7470), 258-258, 2013 | 239 | 2013 |
| Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion A Gutiérrez-Fernández, A Fueyo, AR Folgueras, C Garabaya, ... Cancer research 68 (8), 2755-2763, 2008 | 237 | 2008 |
| Survivin is an independent prognostic marker for risk stratification of breast cancer patients PN Span, FCGJ Sweep, ETG Wiegerinck, VCG Tjan-Heijnen, P Manders, ... Clinical Chemistry 50 (11), 1986-1993, 2004 | 231 | 2004 |
